Perspective on model‐informed drug development

Model‐informed drug development (MIDD) is a process intended to expedite drug development, enhance regulatory science, and produce benefits for patients. Quantitative modeling and simulation—principally by population pharmacokinetics (PK), exposure–response, and physiologically based pharmacokinetic...

Descripción completa

Detalles Bibliográficos
Autor principal: Lesko, Lawrence J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520742/
https://www.ncbi.nlm.nih.gov/pubmed/34404115
http://dx.doi.org/10.1002/psp4.12699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520742/
https://www.ncbi.nlm.nih.gov/pubmed/34404115
http://dx.doi.org/10.1002/psp4.12699

Ejemplares similares